1![# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,*,#, Stephen M. Shaw 1,*, Kim Wi # 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,*,#, Stephen M. Shaw 1,*, Kim Wi](https://www.pdfsearch.io/img/f7f7d974806d8ed51d91c315573d9d57.jpg) | Add to Reading ListSource URL: www.biolinerx.comLanguage: English - Date: 2017-03-27 02:02:40
|
---|
2![Microsoft Word - ST64 Cancer Immunotherapy v1.0.docx Microsoft Word - ST64 Cancer Immunotherapy v1.0.docx](https://www.pdfsearch.io/img/52e8ff7c91652f5a2cd3f2c968518c8d.jpg) | Add to Reading ListSource URL: www.proimmune.comLanguage: English - Date: 2016-06-13 06:09:49
|
---|
3![April 18, 2018 Torii Pharmaceutical Co., Ltd. Price Listing on the NHI Reimbursement List and Launch of “CEDARCURE® Japanese Cedar Pollen Sublingual Tablets”, an Allergen Immunotherapy Tablet for Japanese Cedar Poll April 18, 2018 Torii Pharmaceutical Co., Ltd. Price Listing on the NHI Reimbursement List and Launch of “CEDARCURE® Japanese Cedar Pollen Sublingual Tablets”, an Allergen Immunotherapy Tablet for Japanese Cedar Poll](https://www.pdfsearch.io/img/0f0e8f5cb2b182e4d41db851264048be.jpg) | Add to Reading ListSource URL: www.torii.co.jpLanguage: English - Date: 2018-04-17 00:37:00
|
---|
4![第42回 日本免疫学会学術集会 クリニカルセミナー 2 Sublingual immunotherapy for Japanese cedar pollinosis 第42回 日本免疫学会学術集会 クリニカルセミナー 2 Sublingual immunotherapy for Japanese cedar pollinosis](https://www.pdfsearch.io/img/c634516b815ca976ef83d3cf5b1e0c2d.jpg) | Add to Reading ListSource URL: www.jsi-men-eki.orgLanguage: Japanese - Date: 2013-12-26 23:59:34
|
---|
5![President of ORPHEUS Robert Adam Harris Professor in Immunotherapy in Neuroinflammation Karolinska Institutet Personal details: President of ORPHEUS Robert Adam Harris Professor in Immunotherapy in Neuroinflammation Karolinska Institutet Personal details:](https://www.pdfsearch.io/img/dbd5a7b6167f5a42b77987af54f30ef2.jpg) | Add to Reading ListSource URL: www.orpheus-med.orgLanguage: English - Date: 2016-04-12 05:03:24
|
---|
6![BOOK PERFORMANCE METRICS NOV 30, 2017 Immunotherapy - Myths, Reality, Ideas, Future Edited by: Krassimir Metodiev BOOK PERFORMANCE METRICS NOV 30, 2017 Immunotherapy - Myths, Reality, Ideas, Future Edited by: Krassimir Metodiev](https://www.pdfsearch.io/img/d7978a3c02f58e292a96e207d37ec3ba.jpg) | Add to Reading ListSource URL: www.imab-bg.orgLanguage: English - Date: 2017-12-05 05:37:22
|
---|
7![FALL/WINTERUCSF Oncology Connection Oncologist Lawrence Fong, MD, is leading UCSF’s newly launched Cancer Immunotherapy Program FALL/WINTERUCSF Oncology Connection Oncologist Lawrence Fong, MD, is leading UCSF’s newly launched Cancer Immunotherapy Program](https://www.pdfsearch.io/img/790d58efb14877579a322b1124e4d839.jpg) | Add to Reading ListSource URL: cancer.ucsf.edu- Date: 2016-11-10 15:08:46
|
---|
8![Cancer Immunotherapy & Personalized Vaccines Alex Rubinsteyn Mount Sinai, Hammer Lab Cancer Immunotherapy & Personalized Vaccines Alex Rubinsteyn Mount Sinai, Hammer Lab](https://www.pdfsearch.io/img/294ba9b28c1f2a13e7831a4725a12d4c.jpg) | Add to Reading ListSource URL: www.rubinsteyn.com- Date: 2017-03-28 12:28:33
|
---|
9![IMMUNOTHERAPY AND MELANOMA RESEARCH GET BIG BOOST WITH BLOOMBERG-KIMMEL INSTITUTE Washington,
DC,
March
30,
2016
–The
promising
field
of
immunotherapy,
in
which
mela IMMUNOTHERAPY AND MELANOMA RESEARCH GET BIG BOOST WITH BLOOMBERG-KIMMEL INSTITUTE Washington,
DC,
March
30,
2016
–The
promising
field
of
immunotherapy,
in
which
mela](https://www.pdfsearch.io/img/4b053cb35b21cfef7670749f2c57bdad.jpg) | Add to Reading ListSource URL: www.curemelanoma.org- Date: 2016-03-30 14:45:05
|
---|